SCHEMBL24688552

SCHEMBL24688552

COc1cccc(/C(=C(/c2ccccc2)C(C)C)c2ccc(N3CCN(C(C)C)CC3)c(OC)c2)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DRD4 P21917 6/20 0.48
▸ DRD2 P14416 5/20 0.48
▸ MAPT P10636 2/20 0.48
▸ MEN1 O00255 1/20 0.48
▸ KMT2A Q03164 1/20 0.48
▸ ALOX15 P16050 1/20 0.45
▸ TSHR P16473 1/20 0.45
▸ HSD17B10 Q99714 1/20 0.45
▸ GFER P55789 1/20 0.43
▸ SLC6A2 P23975 2/20 0.42
▸ SLC6A3 Q01959 2/20 0.42
▸ SLC6A4 P31645 1/20 0.42
▸ HRH3 Q9Y5N1 1/20 0.42
▸ CHRNA1 P02708 1/20 0.42
▸ CHRNG P07510 1/20 0.42
▸ CHRNB1 P11230 1/20 0.42
▸ CHRNB2 P17787 1/20 0.42
▸ CHRNB4 P30926 1/20 0.42
▸ CHRNA3 P32297 1/20 0.42
▸ CHRNA4 P43681 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24688561 0.86 ESRRG (0.51) DRD4MAPTMEN1KMT2AGFER
SCHEMBL24688549 0.86 CDK4 (0.50) DRD4DRD2MAPTMEN1KMT2A
SCHEMBL24688558 0.79 ESRRG (0.47) MAPTALDH1A1CDK4CCND1
SCHEMBL24688808 0.77 ESRRG (0.50) DRD2MAPTMEN1KMT2AHTR1A
SCHEMBL24688550 0.77 ESRRG (0.52) MAPTMEN1KMT2AALDH1A1GAA
SCHEMBL24688916 0.76 ESRRG (0.49) MAPTALDH1A1
SCHEMBL24688547 0.76 ESRRG (0.49) MAPTCDK4CCND1
SCHEMBL24688929 0.76 ESRRG (0.51) MAPTALDH1A1CDK4CCND1
SCHEMBL29968359 0.72 ESRRG (0.57) MAPTALDH1A1
SCHEMBL24688546 0.72 ESRRG (0.67) MAPTMEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022245124-A1 NOVEL ETHENE COMPOUND AND PHARMACEUTICAL COMPOSITION INCLUDING SAME AS ACTIVE INGREDIENT FOR PREVENTION OR TREATMENT OF CANCER 재단법인 대구경북첨단의료산업진흥재단 2022-11-24 — — WO disclosed
Send feedback